SCHEMBL17833384

SCHEMBL17833384

CCC(=O)N[C@H](C)COC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
HPGD P15428 5/20 0.44
ALDH1A1 P00352 4/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
CYP2C9 P11712 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
ACACB O00763 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
POLB P06746 1/20 0.36
ATM Q13315 1/20 0.36
MAPT P10636 1/20 0.36
HCAR3 P49019 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13912219 1.00 LMNA (0.44) LMNAHPGDALDH1A1HTTRAB9A
SCHEMBL17833383 1.00 LMNA (0.44) LMNAHPGDALDH1A1HTTRAB9A
SCHEMBL24405481 0.85 CYP2C9 (0.36) LMNAHPGDALDH1A1HTTRAB9A
SCHEMBL15686682 0.84 CYP2C9 (0.45) LMNACYP2C9MEN1KMT2AACACB
SCHEMBL27659242 0.80 CYP2C9 (0.38) LMNAALDH1A1HTTCYP2C9MEN1
SCHEMBL25594538 0.80 CYP2C9 (0.45) LMNAHPGDCYP2C9MEN1KMT2A
SCHEMBL22928949 0.79 ALDH1A1 (0.44) LMNAHPGDALDH1A1HTTRAB9A
SCHEMBL22425847 0.79 CYP2C9 (0.41) LMNACYP2C9MEN1KMT2AL3MBTL1
SCHEMBL25099324 0.79 CYP2C9 (0.41) LMNAHPGDALDH1A1HTTRAB9A
SCHEMBL16730101 0.78 LMNA (0.41) LMNAHPGDALDH1A1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 US disclosed
WO-2016092327-A1 PRO-SURVIVAL COMPOUNDS UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) 2016-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS MCL1, MKI67, MORF4L1 LMNA 301/4885HPGD 1197/4885ALDH1A1 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.